Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for dry, irritated eyes in glaucoma patients?

NCT ID NCT04354545

First seen Mar 26, 2026 · Last updated May 24, 2026 · Updated 6 times

Summary

This study looks at whether Xiidra, an FDA-approved eye drop for dry eye, can help glaucoma patients who have eye discomfort from using multiple eye pressure-lowering medications. About 75 adults who already take glaucoma drops and have dry eye symptoms will receive Xiidra as part of their regular care. Researchers will measure changes in eye surface health, dryness scores, and quality of life over 12 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Doheny Eye Center UCLA

    RECRUITING

    Fountain Valley, California, 92708, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.